Sustained Release Olanzapine

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$100,000.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43MH068925-01A1
Agency Tracking Number:
MH068925
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
AURITEC PHARMACEUTICALS, INC.
AURITEC PHARMACEUTICALS, INC., 2275 E FOOTHILL BLVD, PASADENA, CA, 91107
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 THOMAS Smith
 (617) 461-6263
 TSMITH@AURITECPHARMA.COM
Business Contact
Phone: (626) 376-4070
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The long-term goal of this research is to minimize morbidity associated with psychotic disorders by developing injectable long-acting formulations of olanzapine (Zyprexa/R), currently a leading atypical antipsychotic a

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government